{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-008623","form_type":"8-K","ticker":"XBIO","cik":"0001534525","company_name":"Xenetic Biosciences, Inc.","filed_at":"2022-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.061931+00:00","generated_at":"2026-06-21T00:02:56.244515+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Xenetic stockholders approve increase in authorized common stock from 50M to 100M shares","bullets":["Proposal Four passed: 7,204,486 For, 1,131,034 Against, 110,245 Abstained, no broker non-votes.","Amendment to Articles of Incorporation increases authorized common stock from 50M to 100M shares.","Annual meeting reconvened on Dec. 21, 2022 solely for this proposal after initial adjournment on Dec. 7, 2022.","No other matters were considered or voted upon at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-008623","json":"https://secwatch.observer/filing/0001683168-22-008623.json","markdown":"https://secwatch.observer/filing/0001683168-22-008623.md","text":"https://secwatch.observer/filing/0001683168-22-008623.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534525/000168316822008623/0001683168-22-008623-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534525/000168316822008623/xenetic_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T00:02:56.244515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ef67dbcce7d21e72b994420b99db0cd3ca2b609a","claim":"Xenetic Biosciences, Inc. shareholders approved Amendment to increase authorized common stock from 50,000,000 to 100,000,000 shares at the 2022-12-21 meeting.","evidence_excerpt":"Proposal Four : The Company’s stockholders voted upon and approved and adopted an amendment to the Company’s Articles of Incorporation to increase the authorized number of shares of the Company’s common stock from 50,000,000 shares to 100,000,000 shares. The votes on this proposal were as follows: For Against Abstained Broker Non-Votes 7,204,486 1,131,034 110,245 –","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316822008623/0001683168-22-008623-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-21"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}